Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial progenitor cells
- 31 December 2009
- journal article
- research article
- Published by Elsevier BV in Journal of Vascular Surgery
- Vol. 50 (6), 1412-1422
- https://doi.org/10.1016/j.jvs.2009.08.007
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studiesThe Lancet, 2008
- Oxidant Stress Impairs In Vivo Reendothelialization Capacity of Endothelial Progenitor Cells From Patients With Type 2 Diabetes MellitusCirculation, 2007
- Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1αJCI Insight, 2007
- Type-2 Diabetic Leprdb/db Mice Show a Defective Microvascular Phenotype under basal conditions and an Impaired Response to Angiogenesis Gene Therapy in the setting of Limb IschemiaFrontiers in Bioscience-Landmark, 2007
- Hypercholesterolemia Reduces Collateral Artery Growth More Dominantly Than Hyperglycemia or Insulin Resistance in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Animal models of diabetes mellitusDiabetic Medicine, 2005
- The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemiaJournal of Vascular Surgery, 2005
- Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agentsJournal of Applied Physiology, 2004
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Diabetes, a New Mutation in the MouseScience, 1966